Comparison of two antifibrotic treatments for lung fibrosis in post-COVID-19 syndrome: A randomized, prospective study
Buğra Kerget, Gizem Çil, Ömer Araz, Fatih Alper, Metin Akgün
Topics & Concepts
PirfenidoneNintedanibMedicineIdiopathic pulmonary fibrosisInternal medicineAdverse effectGastroenterologyPneumoniaPulmonary fibrosisTolerabilityFibrosisLungInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisLong-Term Effects of COVID-19COVID-19 Clinical Research Studies